Results
1 -
10 of
996
(Click
here to explore results)
- Oxidative Stress and Redox Signalling in Parkinson’s Disease, CHAPTER 1 Etiology and Pathogenesis of Parkinson’s Disease. Briana R. de Miranda, J. Timothy Greenamyre
, 2017
, Pages 1-26
- The Dictionary of Substances and their Effects (DOSE): D (2), D Compounds. N. N. Greenwood
, 1999
, Volume 3
, Pages 1-832
- Drug Discovery for Schizophrenia, CHAPTER 9 Protein Interactions with Dopamine Receptors as Potential New Drug Targets for Treating Schizophrenia. Ping Su, Albert H. C. Wong, Fang Liu
, 2015
, Pages 202-233
- Drug Discovery for Psychiatric Disorders, CHAPTER 2 The Pathophysiology of Schizophrenia. Armin Szegedi, Michael Egan
, 2012
, Pages 13-34
- Human Stem Cell Toxicology, Chapter 4 The Role of Catecholamines in Stem Cell Mobilisation. Bríd M. Ryan, Oscar Vidal
, 2016
, Pages 64-93
- Functional Polymer Composites with Nanoclays, CHAPTER 12 Halloysite–Dopamine Hybrid Nanotubes to Immobilize Biomacromolecules. Yifan Li, Yafei Zhao, Bing Zhang, Rongfeng Chen
, 2017
, Pages 329-353
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 12 Phosphodiesterase Inhibitors as a New Therapeutic Approach for the Treatment of Parkinson’s Disease. Ana Martinez, Carmen Gil
, 2013
, Pages 294-307
- Oxidative Stress and Redox Signalling in Parkinson’s Disease, CHAPTER 14 Dietary Anti-, Pro-Oxidants in the Etiology of Parkinson’s Disease. Zeynep Sena Agim, Jason R. Cannon
, 2017
, Pages 447-504
- Redox Polymers for Energy and Nanomedicine, Chapter 7 Catechol-containing Polymers for Electrochemical Energy Storage. Nagaraj Patil, Rebeca Marcilla
, 2021
, Pages 245-287
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 9 New Approaches to Neuroprotection in Parkinson’s Disease. María Angeles Mena, Juan Perucho, José Luis López-Sendón, Justo García de Yébenes
, 2013
, Pages 219-236